Standard Infusion Carboplatin Versus Prophylactic Extended Infusion Carboplatin in Patients With Patients With Recurrent, Ovary, Fallopian Tube, and Primary Peritoneal Cancer

NCT01248962 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

146

Enrollment

OTHER

Sponsor class

Conditions

Ovarian Cancer
Fallopian Tube Cancer
Peritoneal Cancer

Interventions

DRUG: carboplatin
DRUG: carboplatin

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]